• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从红色糖多孢菌、阿佛曼链霉菌和灰色链霉菌中鉴定出的新型 III 类细菌素——红霉素肽、avermipeptin 和 griseopeptin 的特征是逐步的 N 端前导肽加工。

Characterization of new class III lantibiotics--erythreapeptin, avermipeptin and griseopeptin from Saccharopolyspora erythraea, Streptomyces avermitilis and Streptomyces griseus demonstrates stepwise N-terminal leader processing.

机构信息

Technische Universität Berlin, Institut für Chemie, 10623 Berlin, Germany.

出版信息

Chembiochem. 2012 May 29;13(8):1174-83. doi: 10.1002/cbic.201200118. Epub 2012 May 3.

DOI:10.1002/cbic.201200118
PMID:22556031
Abstract

Lantibiotics are a large group of ribosomally synthesized peptides post-translationally modified to incorporate the amino acid lanthionine. They are classified, according to their biosynthetic pathway and bioactivity, into three major subtypes. Of Actinomycetes type III lantibiotics, only four peptides (SapB, SapT, LabA1, and LabA2) have been described and structurally characterized, although homologous gene clusters are abundant in other Actinomycetes. All these gene clusters share a similar architecture with a characteristic Ser/Ser/Cys motif in precursor peptides, which has previously been suggested to act as a precursor for lanthionine (SapB) and labionin (LabA2) rings. Mass spectrometry screening led to the discovery and characterization of three new representatives of type III lantibiotics: Avermipeptin (Avi), Erythreapeptin (Ery), and Griseopeptin (Gri) from Streptomyces avermitilis DSM 46492, Saccharopolyspora erythraea NRRL 2338, and Streptomyces griseus DSM 40236, respectively. Apart from the assignment of these peptides to their corresponding gene clusters, additional investigations on Avi, Ery and Gri peptides indicate stepwise leader processing by putative aminopeptidase-like protease(s), thus yielding mixtures of differently N-terminal-processed lantibiotic peptides. Similar peptide processing was observed for a heterologously expressed eryth biosynthetic gene cluster expressed in a Streptomyces host system. Remarkably, all isolates of the new type III lantibiotics contain both the amino acids lanthionine and labionin, thus implying dual-mode cyclase activity of the processing lyase-kinase-cyclase enzymes. These findings have implications for the structures and maturation of other type III lantibiotics from Actinomycetes.

摘要

类杆菌素是一大类核糖体合成的肽类,经翻译后修饰后掺入氨基酸 lanthionine。根据其生物合成途径和生物活性,它们被分为三个主要亚型。在放线菌 III 型类杆菌素中,只有 4 种肽(SapB、SapT、LabA1 和 LabA2)被描述和结构表征,尽管在其他放线菌中存在丰富的同源基因簇。所有这些基因簇都具有相似的结构,前体肽中的特征 Ser/Ser/Cys 基序,以前曾被认为是 lanthionine(SapB)和 labionin(LabA2)环的前体。质谱筛选导致发现和表征了三种新型 III 型类杆菌素的代表:Avermipeptin(Avi)、Erythreapeptin(Ery)和 Griseopeptin(Gri),分别来自链霉菌avermitilis DSM 46492、红串红球菌 NRRL 2338 和灰色链霉菌 DSM 40236。除了将这些肽分配到它们相应的基因簇之外,对 Avi、Ery 和 Gri 肽的进一步研究表明,假定的氨肽酶样蛋白酶(s)逐步进行前导肽加工,从而产生不同 N 末端加工的类杆菌素肽混合物。在链霉菌宿主系统中表达的异源表达 eryth 生物合成基因簇中观察到类似的肽加工。值得注意的是,新型 III 型类杆菌素的所有分离株都含有 lanthionine 和 labionin,这意味着加工裂解酶-激酶-环化酶的双模式环化酶活性。这些发现对放线菌中其他 III 型类杆菌素的结构和成熟具有重要意义。

相似文献

1
Characterization of new class III lantibiotics--erythreapeptin, avermipeptin and griseopeptin from Saccharopolyspora erythraea, Streptomyces avermitilis and Streptomyces griseus demonstrates stepwise N-terminal leader processing.从红色糖多孢菌、阿佛曼链霉菌和灰色链霉菌中鉴定出的新型 III 类细菌素——红霉素肽、avermipeptin 和 griseopeptin 的特征是逐步的 N 端前导肽加工。
Chembiochem. 2012 May 29;13(8):1174-83. doi: 10.1002/cbic.201200118. Epub 2012 May 3.
2
Curvopeptin: a new lanthionine-containing class III lantibiotic and its co-substrate promiscuous synthetase.卷曲菌素:一种新型含硫氨酸的 III 类羊毛硫抗生素及其共底物混杂合成酶。
Chembiochem. 2012 Sep 24;13(14):2065-71. doi: 10.1002/cbic.201200417. Epub 2012 Aug 20.
3
Leader peptide-directed processing of labyrinthopeptin A2 precursor peptide by the modifying enzyme LabKC.导向肽引导 LabKC 对 labyrinthopeptin A2 前体肽的加工。
Biochemistry. 2011 Oct 4;50(39):8362-73. doi: 10.1021/bi200526q. Epub 2011 Sep 9.
4
Effect of bioengineering lacticin 3147 lanthionine bridges on specific activity and resistance to heat and proteases.生物工程改造的乳酸链球菌素3147羊毛硫氨酸桥对比活性以及耐热性和蛋白酶抗性的影响。
Chem Biol. 2010 Oct 29;17(10):1151-60. doi: 10.1016/j.chembiol.2010.08.011.
5
Lanthionine introduction into nukacin ISK-1 prepeptide by co-expression with modification enzyme NukM in Escherichia coli.通过与修饰酶NukM在大肠杆菌中共表达将羊毛硫氨酸引入核杀菌素ISK-1前肽。
Biochem Biophys Res Commun. 2005 Oct 21;336(2):507-13. doi: 10.1016/j.bbrc.2005.08.125.
6
Deuterium labeled peptides give insights into the directionality of class III lantibiotic synthetase LabKC.氘标记的肽为研究 III 类羊毛硫抗生素合成酶 LabKC 的方向性提供了线索。
J Am Chem Soc. 2012 Jun 20;134(24):9922-5. doi: 10.1021/ja3040224. Epub 2012 Jun 11.
7
Roseocin, a novel two-component lantibiotic from an actinomycete.玫瑰菌素,一种新型放线菌两组分类细菌素。
Mol Microbiol. 2020 Feb;113(2):326-337. doi: 10.1111/mmi.14419. Epub 2019 Nov 27.
8
Unique peptide modifications involved in the biosynthesis of lantibiotics.羊毛硫抗生素生物合成中涉及的独特肽修饰。
Trends Biotechnol. 1995 Jul;13(7):269-78. doi: 10.1016/S0167-7799(00)88962-3.
9
Posttranslationally modified bacteriocins--the lantibiotics.翻译后修饰的细菌素——羊毛硫抗生素。
Biopolymers. 2000;55(1):62-73. doi: 10.1002/1097-0282(2000)55:1<62::AID-BIP60>3.0.CO;2-Y.
10
Discovery of unique lanthionine synthetases reveals new mechanistic and evolutionary insights.发现独特的羊毛硫氨酸合成酶揭示了新的机制和进化见解。
PLoS Biol. 2010 Mar 23;8(3):e1000339. doi: 10.1371/journal.pbio.1000339.

引用本文的文献

1
Mechanistic insights into lanthipeptide modification by a distinct subclass of LanKC enzyme that forms dimers.关于形成二聚体的独特 LanKC 酶家族对硫肽修饰的机制见解。
Nat Commun. 2024 Aug 17;15(1):7090. doi: 10.1038/s41467-024-51600-6.
2
BGCFlow: systematic pangenome workflow for the analysis of biosynthetic gene clusters across large genomic datasets.BGCFlow:用于分析大型基因组数据集生物合成基因簇的系统泛基因组工作流程。
Nucleic Acids Res. 2024 Jun 10;52(10):5478-5495. doi: 10.1093/nar/gkae314.
3
Proteases Involved in Leader Peptide Removal during RiPP Biosynthesis.
核糖体合成的天然产物生物合成过程中参与前导肽去除的蛋白酶
ACS Bio Med Chem Au. 2023 Dec 13;4(1):20-36. doi: 10.1021/acsbiomedchemau.3c00059. eCollection 2024 Feb 21.
4
The untapped potential of actinobacterial lanthipeptides as therapeutic agents.放线菌硫肽类抗生素作为治疗药物的未开发潜力。
Mol Biol Rep. 2023 Dec;50(12):10605-10616. doi: 10.1007/s11033-023-08880-w. Epub 2023 Nov 7.
5
Heterologous Production and Structure Determination of a New Lanthipeptide Sinosporapeptin Using a Cryptic Gene Cluster in an Actinobacterium Sinosporangium siamense.利用链霉菌属中的一个隐蔽基因簇异源生产和结构确定新型硫肽菌素 Sinosporapeptin。
J Microbiol. 2023 Jun;61(6):641-648. doi: 10.1007/s12275-023-00059-z. Epub 2023 Jun 12.
6
sp. NFXS83 in Marine Biotechnological Applications: From Microalgae Growth Promotion to the Production of Secondary Metabolites.海洋生物技术应用中的新种NFXS83:从促进微藻生长到次级代谢产物的生产
Microorganisms. 2023 Mar 30;11(4):902. doi: 10.3390/microorganisms11040902.
7
Refactoring and Heterologous Expression of Class III Lanthipeptide Biosynthetic Gene Clusters Lead to the Discovery of ,-Dimethylated Lantibiotics from Firmicutes.重构和异源表达 III 类聚酮肽生物合成基因簇导致发现厚壁菌纲中的,-二甲基类杆菌肽。
ACS Chem Biol. 2023 Mar 17;18(3):508-517. doi: 10.1021/acschembio.2c00849. Epub 2023 Mar 9.
8
Synthesis of Ribosomally Synthesized and Post-Translationally Modified Peptides Containing C-C Cross-Links.含 C-C 交叉键的核糖体合成和翻译后修饰肽的合成。
J Nat Prod. 2022 Oct 28;85(10):2519-2539. doi: 10.1021/acs.jnatprod.2c00508. Epub 2022 Sep 22.
9
Discovery of a Unique Structural Motif in Lanthipeptide Synthetases for Substrate Binding and Interdomain Interactions.发现兰尼肽合成酶中用于底物结合和结构域间相互作用的独特结构模体。
Angew Chem Int Ed Engl. 2022 Nov 7;61(45):e202211382. doi: 10.1002/anie.202211382. Epub 2022 Oct 7.
10
Comprehensive genome analysis of Lentzea reveals repertoire of polymer-degrading enzymes and bioactive compounds with clinical relevance. Lentzea 的全基因组分析揭示了具有临床相关性的聚合物降解酶和生物活性化合物的库。
Sci Rep. 2022 May 19;12(1):8409. doi: 10.1038/s41598-022-12427-7.